z-logo
open-access-imgOpen Access
Effectiveness and Safety of Certolizumab Pegol in Axial Spondyloarthritis in a Real-World Setting in Greece: A Sub-Analysis of the Prospective Non-Interventional CIMAX Cohort Study
Author(s) -
Gikas Katsifis,
Athina Theodoridou,
Andreas Bounas,
Panagiotis Georgiou,
Petros P. Sfikakis,
Kalliopi Fragiadaki,
Theodoros Dimitroulas,
Evangelia Mole,
Lars Bauer,
T. Kumke,
Bengt Hoepken
Publication year - 2022
Publication title -
mediterranean journal of rheumatology
Language(s) - English
Resource type - Journals
ISSN - 2529-198X
DOI - 10.31138/mjr.33.1.162
Subject(s) - certolizumab pegol , medicine , axial spondyloarthritis , basdai , ankylosing spondylitis , cohort , population , physical therapy , sacroiliitis , disease , psoriatic arthritis , environmental health , adalimumab

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom